It is now apparent that the gp701 envelope glycoprotein of murine leukemia virus (MuLV) is frequently expressed in mice that are not producing detectable amounts of MuLV (1) (2) (3) (4) . Furthermore, at least two species of th'e gp70 molecule have been distinguished (5) . These may be referred to provisionally as G~x-gp70, found on 129 thymocytes, and 0-gp70, found on C57BL/6 (B6) thymocytes, on the basis of the presence or absence of the G~x type-specificity. These gp70 variants are coded or regUlated by different unlinked genes; the thymocytes of an inbred mouse may express either, both, or neither (5) . The recogflition of distinct variants of gp70 offers new opportunities for exploring the role of C-type viral genomes in oncogenesis. Thus, it should become possible: (a) to relate particular gp70 species to particular types of ecotropic and xenotropic C-type viruses, whose oncogenic potentials may differ, and (b) to assess whether susceptibility to oncogenesis of any sort may be associated with constitutive expression of one or another gp70 species. For these reasons, as well as the general interest in this class of molecules, it seems important to identify other distinct gp70 variants of the mouse as a basis for assessing their biological significance, We report here the recognition of a third variant which we tentatively name X-gp70.
The three antisera used in this study are named and briefly described in Table  I . All three are standard typing sera used in serological tests in this laboratory. All three are known to label virions in immunoelectronmicroscopy (6) , although in the case of aTL (the usual serum used for TL typing; a, anti) this reaction with virions is almost certainly due to agp70 antibody generated by the TL + leukemia cells used for immunization and presumably has no relation to the TL antigens themselves.
The technique of surface iodination of cells bearing gp70 and detergent (Nonidet P-40 or NP-40) lysis of labeled cells, followed by immunoprecipitation of gp70 and subsequent sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out as before (4) . (BALB/c x B6)FI antiradiation leukemia BALB/c RLc~ 1
Standard antiserum for C~x-typing by cytotoxicity assay; also contains antibody to group-specific antigen of gp70
Standard typing serum for X.1 leukemia-associated antigen in the cytotoxicity assay
Standard typing serum for TL antigen on normal thymocytes and leukemia cells (TL.1,2,3) by cytotoxicity assay cites cells), and (c) the transplanted Gix-(E. Stockert, personal communication) spontaneous leukemia ASL1 (cells obtained from spleens of passage mice). Strain A thymocytes are G~x +, and both leukemias are producing virions; thus, as expected, aNTD (which contains antibody to gp70 group-specific antigen [5, 8] ) precipitated gp70 from all three cell types ( Fig. 1 a-c ). But aX. 1 ( Fig. 1 d-f) and aTL ( Fig. 1 g-i) precipitated gp70 only from the two leukemia lines, not from thymocytes. 2 Therefore the two leukemias express a gp70 variant which is not detectable on A-strain thymocytes. It cannot be Gxx-gp70, and it is identified by both aX.1 and aTL. Provisionally, we propose to call this gp70 variant 'X-gp70.' A more systematic nomenclature for members of the gp70 molecular species will be called for in due course. In the meantime we chose the arbitrary and neutral prefix 'X' because X-gp70 was first recognized with X.1 antiserum. The X.1 system (10) was so named because antibodies to X. 1 antigens are formed by mice (i.e., within the species), and the X. 1 immune response is under the control oflr genes, which suggested an interpretation of the 'X' antigens which Gorer et al. (11) demonstrated serologically in mouse leukemia cells many years ago. The presence of aX-gp70 antibody in the aTL antiserum is explained by the fact that the TL + leukemia used for producing this particular TL antiserum is ASL1. Fig. 2 summarizes studies with RADA1 leukemia cells which demonstrate that two distinct variants of gp70 are carried by the A-strain leukemias. This conclusion is based on the argument that: (a) if aX. 1 and aTL identify a typespecific gp70 (X-gp70) then removal of this gp70 by immunoprecipitation with either antiserum should leave in solution the other gp70, precipitable in turn by reaction with aNTD; and (b), on the other hand, precipitation with aNTD should leave nothing that can subsequently be precipitated by aX. 1 and aTL. Both aX.1 and aTL remove gp70 precipitable by either antiserum (Fig. 2  e,f,h,i) , but leave gp70 precipitable by aNTD (Fig. 2 b,c) , which confirms (a) above; aNTD removes all gp70 precipitable by any of the three antisera (Fig. 2  a,d,g ), illustrating that (b) also is correct. Thus RADA1 leukemia cells carry two species of gp70, one of which can be accounted for as the Gix-gp70, which is present on A-strain thymocytes, and another which is not present on A thymocytes and which we call X-gp70. The gp70 discovered on B6 thymocytes in Fla. 2. Sequential immunoprecipitations. The three column headings (<Previously cleared with aNTD, aX.1, or aTL') refer to the preparatory treatment of each antiserum. This consisted in reacting NP-40 lysates of surface-iodinated RADA1 cells with an excess of the antiserum indicated by the heading, followed by anti-immunoglobulin at equivalent concentration, both predetermined by titration. Control experiments indicated that such a 'clearing' step did not affect detection of a second antigen exemplified by precipitation of H-2 antigen before and after <clearing' (data not shown). Peaks of gp70 are visible in panels b and c, In panels g and h precipitation of TL antigen is visible against a background peak of autoprecipitating cell protein near the same position in the gel (cf. Fig. 1 ).
previous work (5) is neither Gtx-gp70, because B6 thymocytes are Gin- (7), nor Xgp70, because aX. 1 precipitates no gp70 from B6 thymocytes (data not given). Provisionally, the notation 0-gp70 seems appropriate for this other gp70, the '0' signifying that no type specificity has yet been established for this molecule. Comment This report is limited to results with cells of A-strain origin because these findings, taken in conjuction with our earlier data, are adequate to establish the existence of the third type of MuLV gp70. It is known that G,x-gp70 and 0-gp70 are coded or specified by unlinked loci and so constitute two discrete genetic systems, possibly two different integrated MuLV genomes. It would seem likely that X-gp70 constitutes a third independent locus, but proof of this is lacking. In studies of several mouse strains other than A, we have found X-gp70 only on leukemia cells which are producing virus or on cells from strains such as AKR which produce large amounts of virus; thus AKR thymocytes express X-gp70. But although the X-gp70 + phenotype appears to be associated with productive infection, the X-gp70 + genotype is clearly not so restricted. Thus for example thymocytes of BALB/c mice do not have precipitable X,gp70; yet the BALB/c radiation leukemia RLc~ 1 (Table I) is X-gp70 + (data not shown). G~x-mice simiLarly may produce G~x + leukemias, and in this respect there is a resemblance between the X-gp70 and G~x-gp70 systems. However, Gxx-gp70, unlike X-gp70 (on present evidence), can be expressed without productive infection. [Aoki and :oworkers (6, 12) find that RADA1 leukemia cells produce three types ofvirions identifiable by immunoelectronmicroscopy with a set of typing sera including ~X.1. This accords with the occurrence of at least two gp70 species on RADA1 cells, since these visual distinctions may well be largely due to antigenic variants of gp70.] The most pointed distinction between GLx-gp70 and 0-gp70 on the one hand and X-gp70 on the other is that expression of the former two variants is geared to physiological controls governing the differentiation of T cells and need not be accompanied by virus production. So far this has not been observed in the.case of X-gp70.
Summary
Three variants of the gp70 envelope component of MuLV are now recognizable serologically: G~x-gp70, 0-gp70, and X-gp70. The last of these, X-gp70, has so far been found only in mice or cells producing abundant C-type virus. This distinguishes X-gp70, provisionally, from the G~x-gp70 and 0-gp70 variants, each of which can be expressed on normal thymocytes without accompanying virus production, as exemplified by mouse strains 129 and B6, respectively. The Xgp70 genotype, however, is not limited to strains of mice-producing abundant virus, because X-gp70 + leukemias occur in strains of mice which do not produce a great deal of virus and whose thymocytes and other tissues are X-gp70-; this is analogous to the appearance of G~x + leukemias in G~x-mouse strains.
